NO325345B1 - Fremgangsmate for fremstilling av ecteinascidin 770 og ecteinascidin 743, mellomprodukter for anvendelse ved fremgangsmaten, samt fremgangsmate for fremstilling av mellomproduktene - Google Patents

Fremgangsmate for fremstilling av ecteinascidin 770 og ecteinascidin 743, mellomprodukter for anvendelse ved fremgangsmaten, samt fremgangsmate for fremstilling av mellomproduktene Download PDF

Info

Publication number: NO325345B1
Authority: NO; Norway
Prior art keywords: compound; formula; following structure; mmol; equiv
Prior art date: 1996-09-18

Application number

NO19991301A

Other languages

English (en)

Norwegian (no)

Other versions

NO991301D0 (no

NO991301L (no

Inventor

Elias J Corey

David Gin

Original Assignee

Harvard College

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-18

Filing date

1999-03-17

Publication date

2008-04-07

1999-03-17 Application filed by Harvard College filed Critical Harvard College

1999-03-17 Publication of NO991301D0 publication Critical patent/NO991301D0/no

1999-05-14 Publication of NO991301L publication Critical patent/NO991301L/no

2008-04-07 Publication of NO325345B1 publication Critical patent/NO325345B1/no

Links

238000000034 method Methods 0.000 title claims abstract description 19
PKVRCIRHQMSYJX-AIFWHQITSA-N trabectedin Chemical compound C([C@@]1(C(OC2)=O)NCCC3=C1C=C(C(=C3)O)OC)S[C@@H]1C3=C(OC(C)=O)C(C)=C4OCOC4=C3[C@H]2N2[C@@H](O)[C@H](CC=3C4=C(O)C(OC)=C(C)C=3)N(C)[C@H]4[C@@H]21 PKVRCIRHQMSYJX-AIFWHQITSA-N 0.000 title claims abstract description 16
229960000977 trabectedin Drugs 0.000 title claims abstract description 13
XXPXYPLPSDPERN-UHFFFAOYSA-N Ecteinascidin 743 Natural products COc1cc2C(NCCc2cc1O)C(=O)OCC3N4C(O)C5Cc6cc(C)c(OC)c(O)c6C(C4C(S)c7c(OC(=O)C)c(C)c8OCOc8c37)N5C XXPXYPLPSDPERN-UHFFFAOYSA-N 0.000 title claims abstract description 12
YMAUZYADYYYPHZ-UHFFFAOYSA-N Ecteinascidin 770 Natural products COc1cc2C(NCCc2cc1O)C(=O)OCC3N4C(C#N)C5Cc6cc(C)c(OC)c(O)c6C(C4C(S)c7c(OC(=O)C)c(C)c8OCOc8c37)N5C YMAUZYADYYYPHZ-UHFFFAOYSA-N 0.000 title claims description 8
BGFXHQYUWCGGLL-QWIBJBKUSA-N ecteinascidin 770 Chemical compound C([C@@]1(C(OC2)=O)NCCC3=C1C=C(C(=C3)O)OC)S[C@@H]1C3=C(OC(C)=O)C(C)=C4OCOC4=C3[C@H]2N2[C@@H](C#N)[C@H](CC=3C4=C(O)C(OC)=C(C)C=3)N(C)[C@H]4[C@@H]21 BGFXHQYUWCGGLL-QWIBJBKUSA-N 0.000 title claims description 8
239000000543 intermediate Substances 0.000 title abstract 3
230000015572 biosynthetic process Effects 0.000 claims abstract description 15
150000001875 compounds Chemical class 0.000 claims description 63
239000000203 mixture Substances 0.000 claims description 40
-1 (3-unsaturated malonic acid ester Chemical class 0.000 claims description 28
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims description 15
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 13
150000001299 aldehydes Chemical class 0.000 claims description 11
239000002808 molecular sieve Substances 0.000 claims description 11
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 11
239000003153 chemical reaction reagent Substances 0.000 claims description 9
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 claims description 6
LGRLWUINFJPLSH-UHFFFAOYSA-N methanide Chemical compound [CH3-] LGRLWUINFJPLSH-UHFFFAOYSA-N 0.000 claims description 6
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 5
235000019445 benzyl alcohol Nutrition 0.000 claims description 5
238000005828 desilylation reaction Methods 0.000 claims description 5
238000004519 manufacturing process Methods 0.000 claims description 5
NSPJNIDYTSSIIY-UHFFFAOYSA-N methoxy(methoxymethoxy)methane Chemical compound COCOCOC NSPJNIDYTSSIIY-UHFFFAOYSA-N 0.000 claims description 5
230000002829 reductive effect Effects 0.000 claims description 5
PBVZQAXFSQKDKK-UHFFFAOYSA-N 3-Methoxy-3-oxopropanoic acid Chemical compound COC(=O)CC(O)=O PBVZQAXFSQKDKK-UHFFFAOYSA-N 0.000 claims description 4
238000006969 Curtius rearrangement reaction Methods 0.000 claims description 4
239000013067 intermediate product Substances 0.000 claims description 4
125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 4
230000003647 oxidation Effects 0.000 claims description 4
238000007254 oxidation reaction Methods 0.000 claims description 4
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
WJXQFVMTIGJBFX-UHFFFAOYSA-N 4-methoxytyramine Chemical compound COC1=CC=C(CCN)C=C1O WJXQFVMTIGJBFX-UHFFFAOYSA-N 0.000 claims description 3
FTUOOHMRWMKTAD-UHFFFAOYSA-N 7-methyl-6-phenylmethoxy-1,3-benzodioxole-5-carbaldehyde Chemical compound CC1=C2OCOC2=CC(C=O)=C1OCC1=CC=CC=C1 FTUOOHMRWMKTAD-UHFFFAOYSA-N 0.000 claims description 3
238000005798 acetal elimination reaction Methods 0.000 claims description 3
238000005937 allylation reaction Methods 0.000 claims description 3
235000001014 amino acid Nutrition 0.000 claims description 3
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 3
235000018417 cysteine Nutrition 0.000 claims description 3
238000007275 deallylation reaction Methods 0.000 claims description 3
238000007257 deesterification reaction Methods 0.000 claims description 3
238000007327 hydrogenolysis reaction Methods 0.000 claims description 3
230000033444 hydroxylation Effects 0.000 claims description 3
238000005805 hydroxylation reaction Methods 0.000 claims description 3
238000011065 in-situ storage Methods 0.000 claims description 3
238000002955 isolation Methods 0.000 claims description 3
238000007069 methylation reaction Methods 0.000 claims description 3
238000006884 silylation reaction Methods 0.000 claims description 3
238000005891 transamination reaction Methods 0.000 claims description 3
HYHGLTGCHQJAIK-UHFFFAOYSA-N 3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzaldehyde Chemical compound COC1=C(O[Si](C)(C)C(C)(C)C)C=C(C=O)C=C1O[Si](C)(C)C(C)(C)C HYHGLTGCHQJAIK-UHFFFAOYSA-N 0.000 claims description 2
230000006378 damage Effects 0.000 claims description 2
239000012948 isocyanate Substances 0.000 claims description 2
150000002513 isocyanates Chemical class 0.000 claims description 2
150000002989 phenols Chemical class 0.000 claims description 2
238000007363 ring formation reaction Methods 0.000 claims description 2
SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 claims 3
229940127271 compound 49 Drugs 0.000 claims 3
KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 claims 1
OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 claims 1
OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 claims 1
238000009903 catalytic hydrogenation reaction Methods 0.000 claims 1
125000000686 lactone group Chemical group 0.000 claims 1
238000003786 synthesis reaction Methods 0.000 abstract description 6
239000002246 antineoplastic agent Substances 0.000 abstract description 2
230000003389 potentiating effect Effects 0.000 abstract description 2
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 249
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 158
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 148
239000000243 solution Substances 0.000 description 107
235000019439 ethyl acetate Nutrition 0.000 description 83
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 53
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 34
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 34
238000003818 flash chromatography Methods 0.000 description 31
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 30
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
239000011541 reaction mixture Substances 0.000 description 30
229920006395 saturated elastomer Polymers 0.000 description 28
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 26
238000005160 1H NMR spectroscopy Methods 0.000 description 25
238000006243 chemical reaction Methods 0.000 description 25
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 24
101150041968 CDC13 gene Proteins 0.000 description 23
238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 23
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 23
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 23
229910052938 sodium sulfate Inorganic materials 0.000 description 23
235000011152 sodium sulphate Nutrition 0.000 description 23
239000000725 suspension Substances 0.000 description 23
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 21
239000012044 organic layer Substances 0.000 description 20
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 17
238000010828 elution Methods 0.000 description 17
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 17
238000005481 NMR spectroscopy Methods 0.000 description 15
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
235000017557 sodium bicarbonate Nutrition 0.000 description 15
229910000030 sodium bicarbonate Inorganic materials 0.000 description 15
229910001868 water Inorganic materials 0.000 description 15
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
YMWUJEATGCHHMB-DICFDUPASA-N dichloromethane-d2 Chemical compound [2H]C([2H])(Cl)Cl YMWUJEATGCHHMB-DICFDUPASA-N 0.000 description 13
239000000706 filtrate Substances 0.000 description 13
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
239000007787 solid Substances 0.000 description 12
229960000583 acetic acid Drugs 0.000 description 11
239000011780 sodium chloride Substances 0.000 description 11
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 10
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 10
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 10
239000010410 layer Substances 0.000 description 10
239000000047 product Substances 0.000 description 9
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 8
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
239000000741 silica gel Substances 0.000 description 8
229910002027 silica gel Inorganic materials 0.000 description 8
101100109871 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) aro-8 gene Proteins 0.000 description 7
239000002253 acid Substances 0.000 description 7
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 7
AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 6
229960000549 4-dimethylaminophenol Drugs 0.000 description 6
VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 6
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 6
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 6
UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 6
239000003921 oil Substances 0.000 description 6
JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-dimethylaminophenol Chemical compound CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 description 5
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 5
SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 5
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 5
NYPNCQTUZYWFGG-UHFFFAOYSA-N 2,2-dimethoxyethanol Chemical compound COC(CO)OC NYPNCQTUZYWFGG-UHFFFAOYSA-N 0.000 description 4
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
229910004373 HOAc Inorganic materials 0.000 description 4
238000003776 cleavage reaction Methods 0.000 description 4
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 4
238000004128 high performance liquid chromatography Methods 0.000 description 4
229910052739 hydrogen Inorganic materials 0.000 description 4
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
230000007017 scission Effects 0.000 description 4
229910000104 sodium hydride Inorganic materials 0.000 description 4
DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 4
QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 4
GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 3
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 3
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 3
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 3
150000001412 amines Chemical class 0.000 description 3
YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 3
FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 3
239000012230 colorless oil Substances 0.000 description 3
239000012362 glacial acetic acid Substances 0.000 description 3
239000001257 hydrogen Substances 0.000 description 3
150000002596 lactones Chemical group 0.000 description 3
PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 3
239000011734 sodium Substances 0.000 description 3
239000012312 sodium hydride Substances 0.000 description 3
230000000707 stereoselective effect Effects 0.000 description 3
FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 3
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
150000003526 tetrahydroisoquinolines Chemical class 0.000 description 3
DIOHEXPTUTVCNX-UHFFFAOYSA-N 1,1,1-trifluoro-n-phenyl-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)N(S(=O)(=O)C(F)(F)F)C1=CC=CC=C1 DIOHEXPTUTVCNX-UHFFFAOYSA-N 0.000 description 2
ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 2
BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
BHELZAPQIKSEDF-UHFFFAOYSA-N allyl bromide Chemical compound BrCC=C BHELZAPQIKSEDF-UHFFFAOYSA-N 0.000 description 2
150000001413 amino acids Chemical class 0.000 description 2
125000005219 aminonitrile group Chemical group 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
229910052786 argon Inorganic materials 0.000 description 2
AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
JAMFGQBENKSWOF-UHFFFAOYSA-N bromo(methoxy)methane Chemical compound COCBr JAMFGQBENKSWOF-UHFFFAOYSA-N 0.000 description 2
229910000024 caesium carbonate Inorganic materials 0.000 description 2
239000003638 chemical reducing agent Substances 0.000 description 2
238000005859 coupling reaction Methods 0.000 description 2
229940043279 diisopropylamine Drugs 0.000 description 2
MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
239000012634 fragment Substances 0.000 description 2
238000005984 hydrogenation reaction Methods 0.000 description 2
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
150000002576 ketones Chemical class 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000006138 lithiation reaction Methods 0.000 description 2
ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
230000008018 melting Effects 0.000 description 2
238000002844 melting Methods 0.000 description 2
229940098779 methanesulfonic acid Drugs 0.000 description 2
239000002480 mineral oil Substances 0.000 description 2
235000010446 mineral oil Nutrition 0.000 description 2
239000012074 organic phase Substances 0.000 description 2
239000002245 particle Substances 0.000 description 2
NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
238000000746 purification Methods 0.000 description 2
239000002002 slurry Substances 0.000 description 2
RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 2
239000002904 solvent Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
VXKWYPOMXBVZSJ-UHFFFAOYSA-N tetramethyltin Chemical compound C[Sn](C)(C)C VXKWYPOMXBVZSJ-UHFFFAOYSA-N 0.000 description 2
239000003039 volatile agent Substances 0.000 description 2
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
WBJWXIQDBDZMAW-UHFFFAOYSA-N 2-hydroxynaphthalene-1-carbonyl chloride Chemical compound C1=CC=CC2=C(C(Cl)=O)C(O)=CC=C21 WBJWXIQDBDZMAW-UHFFFAOYSA-N 0.000 description 1
YQHJFPFNGVDEDT-UHFFFAOYSA-N 2-tert-butyl-1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(N(C)C)=NC(C)(C)C YQHJFPFNGVDEDT-UHFFFAOYSA-N 0.000 description 1
PJAIMBYNTXNOCN-UHFFFAOYSA-N 3,6-dibromo-1h-indole Chemical compound BrC1=CC=C2C(Br)=CNC2=C1 PJAIMBYNTXNOCN-UHFFFAOYSA-N 0.000 description 1
FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 1
QJNLUNBGDFUULX-UHFFFAOYSA-N 4-n,4-n'-dimethyl-3h-pyridine-4,4-diamine Chemical compound CNC1(NC)CC=NC=C1 QJNLUNBGDFUULX-UHFFFAOYSA-N 0.000 description 1
MXHVORUHWLKKMZ-UHFFFAOYSA-N 9h-fluoren-9-ylmethanethiol Chemical compound C1=CC=C2C(CS)C3=CC=CC=C3C2=C1 MXHVORUHWLKKMZ-UHFFFAOYSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
MOGWWAFCJNJSFF-UHFFFAOYSA-N C1OC=2C=C(C=CC2O1)COCOCOCC1=CC2=C(C=C1)OCO2 Chemical compound C1OC=2C=C(C=CC2O1)COCOCOCC1=CC2=C(C=C1)OCO2 MOGWWAFCJNJSFF-UHFFFAOYSA-N 0.000 description 1
OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 1
239000002841 Lewis acid Substances 0.000 description 1
241000276498 Pollachius virens Species 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 1
241000720974 Protium Species 0.000 description 1
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
PYHXGXCGESYPCW-UHFFFAOYSA-N alpha-phenylbenzeneacetic acid Natural products C=1C=CC=CC=1C(C(=O)O)C1=CC=CC=C1 PYHXGXCGESYPCW-UHFFFAOYSA-N 0.000 description 1
150000008064 anhydrides Chemical class 0.000 description 1
238000010719 annulation reaction Methods 0.000 description 1
238000011914 asymmetric synthesis Methods 0.000 description 1
238000010533 azeotropic distillation Methods 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
238000004891 communication Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
239000012043 crude product Substances 0.000 description 1
XLJMAIOERFSOGZ-UHFFFAOYSA-M cyanate Chemical compound [O-]C#N XLJMAIOERFSOGZ-UHFFFAOYSA-M 0.000 description 1
238000005988 cycloreversion reaction Methods 0.000 description 1
150000005690 diesters Chemical class 0.000 description 1
POCFBDFTJMJWLG-UHFFFAOYSA-N dihydrosinapic acid methyl ester Natural products COC(=O)CCC1=CC(OC)=C(O)C(OC)=C1 POCFBDFTJMJWLG-UHFFFAOYSA-N 0.000 description 1
AASUFOVSZUIILF-UHFFFAOYSA-N diphenylmethanone;sodium Chemical compound [Na].C=1C=CC=CC=1C(=O)C1=CC=CC=C1 AASUFOVSZUIILF-UHFFFAOYSA-N 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000005886 esterification reaction Methods 0.000 description 1
239000003269 fluorescent indicator Substances 0.000 description 1
230000022244 formylation Effects 0.000 description 1
238000006170 formylation reaction Methods 0.000 description 1
239000011521 glass Substances 0.000 description 1
230000005484 gravity Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
230000010354 integration Effects 0.000 description 1
238000006317 isomerization reaction Methods 0.000 description 1
150000007517 lewis acids Chemical class 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-M malonate(1-) Chemical compound OC(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-M 0.000 description 1
239000000463 material Substances 0.000 description 1
BDGDWWGTAFXEEW-UHFFFAOYSA-N methylsulfinylmethane;oxalyl dichloride Chemical compound CS(C)=O.ClC(=O)C(Cl)=O BDGDWWGTAFXEEW-UHFFFAOYSA-N 0.000 description 1
239000012452 mother liquor Substances 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
238000005935 nucleophilic addition reaction Methods 0.000 description 1
235000006408 oxalic acid Nutrition 0.000 description 1
HVAMZGADVCBITI-UHFFFAOYSA-M pent-4-enoate Chemical compound [O-]C(=O)CCC=C HVAMZGADVCBITI-UHFFFAOYSA-M 0.000 description 1
229940117803 phenethylamine Drugs 0.000 description 1
FHPZOWOEILXXBD-UHFFFAOYSA-N phenylseleninyl benzeneseleninate Chemical compound C=1C=CC=CC=1[Se](=O)O[Se](=O)C1=CC=CC=C1 FHPZOWOEILXXBD-UHFFFAOYSA-N 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
CAEWJEXPFKNBQL-UHFFFAOYSA-N prop-2-enyl carbonochloridate Chemical compound ClC(=O)OCC=C CAEWJEXPFKNBQL-UHFFFAOYSA-N 0.000 description 1
125000006239 protecting group Chemical group 0.000 description 1
BGUWFUQJCDRPTL-UHFFFAOYSA-N pyridine-4-carbaldehyde Chemical compound O=CC1=CC=NC=C1 BGUWFUQJCDRPTL-UHFFFAOYSA-N 0.000 description 1
238000010791 quenching Methods 0.000 description 1
230000000171 quenching effect Effects 0.000 description 1
238000002390 rotary evaporation Methods 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
229910001961 silver nitrate Inorganic materials 0.000 description 1
BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
238000000638 solvent extraction Methods 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
229910001220 stainless steel Inorganic materials 0.000 description 1
239000010935 stainless steel Substances 0.000 description 1
239000011593 sulfur Substances 0.000 description 1
229910052717 sulfur Inorganic materials 0.000 description 1
238000001308 synthesis method Methods 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
MHYGQXWCZAYSLJ-UHFFFAOYSA-N tert-butyl-chloro-diphenylsilane Chemical compound C=1C=CC=CC=1[Si](Cl)(C(C)(C)C)C1=CC=CC=C1 MHYGQXWCZAYSLJ-UHFFFAOYSA-N 0.000 description 1
CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
238000004809 thin layer chromatography Methods 0.000 description 1
238000006177 thiolation reaction Methods 0.000 description 1
238000004448 titration Methods 0.000 description 1
PTMFUWGXPRYYMC-UHFFFAOYSA-N triethylazanium;formate Chemical compound OC=O.CCN(CC)CC PTMFUWGXPRYYMC-UHFFFAOYSA-N 0.000 description 1
230000007306 turnover Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Saccharide Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

NO19991301A 1996-09-18 1999-03-17 Fremgangsmate for fremstilling av ecteinascidin 770 og ecteinascidin 743, mellomprodukter for anvendelse ved fremgangsmaten, samt fremgangsmate for fremstilling av mellomproduktene NO325345B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/715,541 US5721362A (en)	1996-09-18	1996-09-18	Process for producing ecteinascidin compounds
PCT/US1997/016470 WO1998012198A1 (en)	1996-09-18	1997-09-17	Process for producing ecteinascidin compounds

Publications (3)

Publication Number	Publication Date
NO991301D0 NO991301D0 (no)	1999-03-17
NO991301L NO991301L (no)	1999-05-14
NO325345B1 true NO325345B1 (no)	2008-04-07

Family

ID=24874473

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19991301A NO325345B1 (no)	1996-09-18	1999-03-17	Fremgangsmate for fremstilling av ecteinascidin 770 og ecteinascidin 743, mellomprodukter for anvendelse ved fremgangsmaten, samt fremgangsmate for fremstilling av mellomproduktene

Country Status (21)

Country	Link
US (1)	US5721362A (cs)
EP (1)	EP0931083B1 (cs)
JP (1)	JP4425995B2 (cs)
KR (1)	KR100358832B1 (cs)
CN (1)	CN1096463C (cs)
AT (1)	ATE232868T1 (cs)
AU (1)	AU738282B2 (cs)
BR (1)	BR9712073B1 (cs)
CA (1)	CA2266081C (cs)
CZ (1)	CZ299596B6 (cs)
DE (1)	DE69719201T2 (cs)
DK (1)	DK0931083T3 (cs)
ES (1)	ES2192273T3 (cs)
HU (1)	HU229407B1 (cs)
IL (2)	IL128993A0 (cs)
NO (1)	NO325345B1 (cs)
NZ (1)	NZ334704A (cs)
PL (1)	PL188572B1 (cs)
PT (1)	PT931083E (cs)
RU (1)	RU2194709C2 (cs)
WO (1)	WO1998012198A1 (cs)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ301083B6 (cs) *	1998-04-06	2009-11-04	The Board Of Trustees Of The University Of Illinois	Ekteinascidinová sloucenina, farmaceutický prostredek ji obsahující a její použití
KR100643092B1 (ko) *	1998-05-11	2006-11-10	파르마 마르, 에스.에이.	엑테인아시딘 743의 대사산물
US6124292A (en)	1998-09-30	2000-09-26	President And Fellows Of Harvard College	Synthetic analogs of ecteinascidin-743
MY164077A (en) *	1999-05-13	2017-11-30	Pharma Mar Sa	Compositions and uses of et743 for treating cancer
BG65893B1 (bg) *	1999-05-14	2010-04-30	Pharma Mar S.A.	Полусинтетичен метод и нови съединения
GB9918178D0 (en) *	2000-05-15	1999-10-06	Pharma Mar Sa	Synthetic methods
AR035842A1 (es) *	1999-05-14	2004-07-21	Pharma Mar Sa	Metodo de hemisintesis para la formacion de compuestos intermediarios y derivados y de estructuras relacionadas con la ecteinascidina y de tetrahidroisoquinolinfenoles y compuestos intermediarios de aplicacion en dicho metodo
JP2003520801A (ja) *	2000-01-19	2003-07-08	ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク	サフラマイシン−エクテイナシジン系列の化合物、それらの使用及び合成
AU2001238135B2 (en) *	2000-02-11	2006-08-17	President And Fellows Of Harvard College	Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds
US6815544B2 (en)	2000-02-11	2004-11-09	President And Fellows Of Harvard College	Synthetic process for an intermediate for ecteinascidin and phthalascidin compounds
US6569859B1 (en)	2000-02-22	2003-05-27	President And Fellows Of Harvard College	Synthetic analogs of ecteinascidin-743
JP5219323B2 (ja) *	2000-04-12	2013-06-26	ファルマ・マール・ソシエダード・アノニマ	抗腫瘍性エクチナサイジン誘導体
US7919493B2 (en) *	2000-04-12	2011-04-05	Pharma Mar, S.A.	Anititumoral ecteinascidin derivatives
IL152125A (en) *	2000-05-15	2008-04-13	Pharma Mar Sa	Process for the manufacture of ecteinascidin derivatives
US7420051B2 (en) *	2000-05-15	2008-09-02	Pharma Mar, S.A.	Synthetic process for the manufacture of an ecteinaschidin compound
MXPA02011319A (es) *	2000-05-15	2003-06-06	Pharma Mar Sa	Analogos antitumorales de ecteinascidina 743.
CA2447553A1 (en)	2000-11-03	2002-05-23	President And Fellows Of Harvard College	Saframycins, analogues and uses thereof
EA005564B1 (ru) *	2000-11-06	2005-04-28	Фарма Мар, С.А.	Эффективные противоопухолевые лекарственные средства
GB0117402D0 (en) *	2001-07-17	2001-09-05	Pharma Mar Sa	New antitumoral derivatives of et-743
GB0119243D0 (en) *	2001-08-07	2001-10-03	Pharma Mar Sa	Antitumoral analogs of ET-743
JP4208469B2 (ja) *	2002-01-29	2009-01-14	独立行政法人科学技術振興機構	エクテナサイジン類の全合成方法、エクテナサイジン類に類縁構造を持つ前記全合成用中間体化合物類、及び該中間体化合物類の合成方法
GB0202544D0 (en) *	2002-02-04	2002-03-20	Pharma Mar Sa	The synthesis of naturally occuring ecteinascidins and related compounds
GB0312407D0 (en) *	2003-05-29	2003-07-02	Pharma Mar Sau	Treatment
US7183054B2 (en)	2003-06-03	2007-02-27	President And Fellows Of Harvard College	Assay for identifying biological targets of polynucleotide-binding compounds
GB0324201D0 (en) *	2003-10-15	2003-11-19	Pharma Mar Sau	Improved antitumoral combinations
SI1689404T1 (sl) *	2003-11-13	2009-02-28	Pharma Mar Sau	Kombinacija et-743 s 5-fluorouracil pro zdravili za zdravljenje raka
GB0326486D0 (en) *	2003-11-14	2003-12-17	Pharma Mar Sau	Combination treatment
CN1897949A (zh) *	2003-11-14	2007-01-17	马尔药品公司	包含使用et－743和紫杉醇来治疗癌症的联合疗法
AU2005261860A1 (en) *	2004-07-09	2006-01-19	Pharma Mar, S.A.	Use of ecteinascidin in the treatment of cancer in patients with low level of BRCA1
CN100396178C (zh) *	2004-08-06	2008-06-25	中国科学院海洋研究所	一种玻璃海鞘的全人工养殖方法及简易型连续投饵装置
AU2005288696A1 (en) *	2004-09-28	2006-04-06	Pharma Mar S.A., Sociedad Unipersonal	Ecteinascidin compounds as anti -inflammatory agents
RU2359700C2 (ru) *	2004-10-26	2009-06-27	Фарма Мар С.А., Сосьедад Униперсональ	Пегилированный липосомальный доксорубицин в комбинации с эктеинасцидином 743 (ecteinescidin 743)
KR101188691B1 (ko)	2004-10-29	2012-10-09	파르마 마르 에스.에이.	엑티나시딘 및 디사카라이드를 포함하는 제제
GB0522082D0 (en) *	2005-10-31	2005-12-07	Pharma Mar Sa	Formulations
CN101157929B (zh) *	2007-02-02	2012-05-23	中国科学院上海有机化学研究所	番红霉素的生物合成基因簇
CA2703026A1 (en) *	2007-10-19	2009-04-23	Rafael Rosell Costa	Prognostic molecular markers for et-743 treatment
AU2011257277B2 (en)	2010-05-25	2016-02-25	Pharma Mar, S.A.	Synthetic process for the manufacture of ecteinascidin compounds
DK2786753T3 (en)	2010-11-12	2019-04-15	Pharma Mar Sa	Combination therapy with an antitumor antibiotic
CN103304478B (zh) *	2013-06-28	2016-04-20	四川大学	一类合成renieramycins型生物碱的中间体及其制备方法
CN104557850B (zh) *	2013-10-29	2019-07-30	江苏盛迪医药有限公司	一种海鞘碱-743中间体的制备方法
CN103709101B (zh) *	2013-12-19	2016-06-29	四川大学	一类renieramycin G的合成中间体及其制备方法
US11332480B2 (en)	2017-04-27	2022-05-17	Pharma Mar, S.A.	Antitumoral compounds
CN111518110B (zh)	2019-02-01	2023-11-03	博瑞生物医药（苏州）股份有限公司	一种海鞘素化合物及其中间体的制备方法
CN110092802B (zh) *	2019-06-21	2022-01-07	爱斯特（成都）生物制药股份有限公司	一种制备曲贝替定中间体的方法
US20220315605A1 (en) *	2019-06-27	2022-10-06	Msn Laboratories Private Limited, R&D Center	IMPROVED PROCESS FOR THE PREPARATON OF PURE (1'R,6R,6aR,7R,13S,14S,16R)-5-(ACETYLOXY)-3',4',6,6a,7,13,14,16-OCTAHYDRO-6',8,14-TRIHYDROXY-7',9-DIMETHOXY-4,10,23-TRIMETHYLSPIRO[6,16-(EPITHIOPROPANOXYMETH ANO)-7,13-IMINO-12H-1,3-DIOXOLO[7,8]ISOQUINO[3,2-b][3]BENZAZOCINE-20,1'(2'H)-ISOQUINOLIN]-19-ONE POLYMORPH THERE OF
WO2021098992A1 (en)	2019-11-21	2021-05-27	Pharma Mar, S.A.	Methods of treating small cell lung cancer with lurbinectedin formulations
CN114621245A (zh) *	2020-12-11	2022-06-14	江苏恒瑞医药股份有限公司	一种曲贝替定中间体的晶型及其制备方法
US12303506B2 (en)	2022-01-20	2025-05-20	Extrovis Ag	Trabectedin composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5089273A (en) *	1986-06-09	1992-02-18	Board Of Trustees Of The University Of Illinois	Ecteinascidins 729, 743, 745, 759A, 759B and 770
US5256663A (en) *	1986-06-09	1993-10-26	The Board Of Trustees Of The University Of Illinois	Compositions comprising ecteinascidins and a method of treating herpes simplex virus infections therewith
US5149804A (en) *	1990-11-30	1992-09-22	The Board Of Trustees Of The University Of Illinois	Ecteinascidins 736 and 722
DE3923985C1 (cs) *	1989-07-20	1990-06-28	Daimler-Benz Aktiengesellschaft, 7000 Stuttgart, De
GB2252781B (en) *	1991-02-14	1994-08-17	Sanwa Shutter Corp	Architectural shutter curtain device
US5478932A (en) *	1993-12-02	1995-12-26	The Board Of Trustees Of The University Of Illinois	Ecteinascidins

1996
- 1996-09-18 US US08/715,541 patent/US5721362A/en not_active Expired - Lifetime
1997
- 1997-09-17 HU HU0000068A patent/HU229407B1/hu unknown
- 1997-09-17 ES ES97942526T patent/ES2192273T3/es not_active Expired - Lifetime
- 1997-09-17 EP EP97942526A patent/EP0931083B1/en not_active Expired - Lifetime
- 1997-09-17 IL IL12899397A patent/IL128993A0/xx active IP Right Grant
- 1997-09-17 CA CA002266081A patent/CA2266081C/en not_active Expired - Lifetime
- 1997-09-17 KR KR1019997002328A patent/KR100358832B1/ko not_active Expired - Lifetime
- 1997-09-17 PL PL97332206A patent/PL188572B1/pl unknown
- 1997-09-17 DE DE69719201T patent/DE69719201T2/de not_active Expired - Lifetime
- 1997-09-17 CN CN97199846A patent/CN1096463C/zh not_active Expired - Lifetime
- 1997-09-17 WO PCT/US1997/016470 patent/WO1998012198A1/en not_active Ceased
- 1997-09-17 NZ NZ334704A patent/NZ334704A/xx not_active IP Right Cessation
- 1997-09-17 JP JP51483798A patent/JP4425995B2/ja not_active Expired - Lifetime
- 1997-09-17 RU RU99105564/04A patent/RU2194709C2/ru active
- 1997-09-17 CZ CZ0091499A patent/CZ299596B6/cs not_active IP Right Cessation
- 1997-09-17 BR BRPI9712073-1B1A patent/BR9712073B1/pt not_active IP Right Cessation
- 1997-09-17 DK DK97942526T patent/DK0931083T3/da active
- 1997-09-17 AT AT97942526T patent/ATE232868T1/de active
- 1997-09-17 AU AU44205/97A patent/AU738282B2/en not_active Expired
- 1997-09-17 PT PT97942526T patent/PT931083E/pt unknown
1999
- 1999-03-15 IL IL128993A patent/IL128993A/en not_active IP Right Cessation
- 1999-03-17 NO NO19991301A patent/NO325345B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
HUP0000068A2 (hu)	2000-06-28
DE69719201T2 (de)	2003-12-11
ATE232868T1 (de)	2003-03-15
NO991301D0 (no)	1999-03-17
ES2192273T3 (es)	2003-10-01
NO991301L (no)	1999-05-14
IL128993A (en)	2006-06-11
CN1096463C (zh)	2002-12-18
JP4425995B2 (ja)	2010-03-03
JP2001501196A (ja)	2001-01-30
BR9712073A (pt)	2002-01-15
EP0931083A4 (en)	2000-05-24
AU4420597A (en)	1998-04-14
RU2194709C2 (ru)	2002-12-20
WO1998012198A1 (en)	1998-03-26
CZ299596B6 (cs)	2008-09-17
NZ334704A (en)	2000-09-29
EP0931083B1 (en)	2003-02-19
AU738282B2 (en)	2001-09-13
US5721362A (en)	1998-02-24
HUP0000068A3 (en)	2001-12-28
CA2266081A1 (en)	1998-03-26
PT931083E (pt)	2003-07-31
HU229407B1 (en)	2013-12-30
KR100358832B1 (ko)	2002-11-21
CN1237974A (zh)	1999-12-08
DK0931083T3 (da)	2003-05-26
EP0931083A1 (en)	1999-07-28
IL128993A0 (en)	2000-02-17
DE69719201D1 (de)	2003-03-27
KR20000036242A (ko)	2000-06-26
BR9712073B1 (pt)	2013-06-18
PL332206A1 (en)	1999-08-30
CA2266081C (en)	2006-12-12
CZ91499A3 (cs)	1999-08-11
PL188572B1 (pl)	2005-02-28

Legal Events

Date	Code	Title	Description
2017-10-09	MK1K	Patent expired

Publication	Publication Date	Title
EP0931083B1 (en)	2003-02-19	Process for producing ecteinascidin compounds
CZ291626B6 (cs)	2003-04-16	Tricyklické sloučeniny, způsob výroby a použití
Feldman et al.	2013	Synthesis studies on the Melodinus alkaloid meloscine
AU607337B2 (en)	1991-02-28	Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof
WO2009056993A2 (en)	2009-05-07	A process for the synthesis of ramelteon and its intermediates
US6369238B1 (en)	2002-04-09	Processes for the preparation of derivatives of 4a, 5, 9, 10, 11, 12-hexahydro-6H-benzofuro-[3a, 3, 2-ef][2]benzazepine
Wattanasin et al.	1985	Stereocontrolled synthesis of cis-fused hydroisoquinolines by an intramolecular Diels-Alder reaction of (Z)-dienes
Muraoka et al.	1997	Tandem Beckmann and Huisgen–White rearrangement of the9-azabicyclo [3.3. 1] nonan-3-one system. Part 2.1 The secondmode of the rearrangement leading to 6-(prop-1-enyl) piperidin-2-ylaceticacid, a versatile intermediate for the syntheses of piperidine alkaloids (+)-pinidine and (+)-monomorine I
Oliveira Filho et al.	2015	Recent syntheses of frog alkaloid epibatidine
Reddipalli et al.	2011	Stereoselective synthesis of (−)-α-conhydrine
MXPA99002576A (en)	2000-04-24	Process for producing ecteinascidin compounds
Cordero-Vargas et al.	2008	Stereodivergent reduction of enelactams embedded in hexahydroindoles. Synthesis of trans-3-substituted-cis-3a-methyloctahydroindoles
US4769480A (en)	1988-09-06	Benzylamine derivative
Nakatani et al.	2003	Enantioselective total synthesis of (+)-aureol via a BF3· Et2O-promoted rearrangement/cyclization reaction of (+)-arenarol
Zhao et al.	1999	Easy generation of an enantiopure general indolalkaloid building block by kinetic resolution
FI89913B (fi)	1993-08-31	Naftisoxazolkarboxylsyraderivat och foerfarande foer deras framstaellning
Kania	1997	The first enantioselective total synthesis of dolabellatrienone and ecteinascidin 743
Badarau et al.	2019	SYNTHESIS OF 3-AMINO-7-ARYL-8-AZACHROMANS: VALIDATION OF A SYNTHETIC ROUTE WITH ENANTIOSELECTIVE POTENTIAL.
JPH02221A (ja)	1990-01-05	光学活性グリセロール誘導体
Zheng et al.	2010	Concise synthesis of two advanced intermediates for the asymmetric synthesis of polyhydroxylated indolizidine alkaloids
Montoya	2020	The Methods Development Approach to the Synthesis of Phenanthridinone Analogs
PT699676E (pt)	2001-05-31	Forma fisica de derivado de di-hidro-2,3-benzodiazepina
JPH06321829A (ja)	1994-11-22	α，α−ジメチルシクロヘキサンカルビノール誘導体又はその塩
Chen et al.	2013	Synthesis of novel four-fused-ring chromeno-benzoxepinones from salicylaldehydes and 1-benzoxepin-5-ones via the oxa-Michael reaction/aldol condensation.
JPH01230567A (ja)	1989-09-14	光学活性エピクロルヒドリンの立体化学反転法